{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:08:23Z","timestamp":1784725703698,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1532\/ijh97.04081","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T02:36:07Z","timestamp":1104374167000},"page":"458-462","source":"Crossref","is-referenced-by-count":13,"title":["Successful Unrelated Cord Blood Transplantation for Epstein-Barr Virus-Associated Lymphoproliferative Disease with Hemophagocytic Syndrome"],"prefix":"10.1007","volume":"80","author":[{"given":"Taikai","family":"Toubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2141.2001.02936.x","author":"Arico, M","year":"2001","unstructured":"Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001;114: 761-769.","journal-title":"Br J Haematol"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","author":"Janka, GE","year":"2004","unstructured":"Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4-14.","journal-title":"Br J Haematol"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1040-8428(02)00112-9","author":"Ohga, S","year":"2002","unstructured":"Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2002;44: 203-215.","journal-title":"Crit Rev Oncol Hematol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","author":"Grom, AA","year":"2003","unstructured":"Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587-590.","journal-title":"Curr Opin Rheumatol"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2002.03266.x","author":"Suga, N","year":"2002","unstructured":"Suga N, Takada H, Nomura A, et al. Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. Br J Haematol. 2002;116:346-349.","journal-title":"Br J Haematol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"Feldmann, J","year":"2003","unstructured":"Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461-473.","journal-title":"Cell"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/bbmt.2001.v7.pm11529490","volume":"7","author":"Barker, JN","year":"2001","unstructured":"Barker JN, Martin PL, Coad JE, et al. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant. 2001;7:395-399.","journal-title":"Biol Blood Marrow Transplant"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1702138","author":"Ohga, S","year":"2000","unstructured":"Ohga S, Kanaya Y, Maki H, et al. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia. Bone Marrow Transplant. 2000;25: 209-212.","journal-title":"Bone Marrow Transplant"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bmt.1702770","volume":"27","author":"Haut, PR","year":"2001","unstructured":"Haut PR, Kovarik P, Shaw PH,Walterhouse D, Jenson HB, Kletzel M. Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation. Bone Marrow Transplant. 2001;27:761-765.","journal-title":"Bone Marrow Transplant"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","author":"Imashuku, S","year":"2002","unstructured":"Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259-272.","journal-title":"Crit Rev Oncol Hematol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2141.2002.03773.x","author":"Arico, M","year":"2002","unstructured":"Arico M, Allen M, Brusa S, et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Haematol. 2002;119:180-188.","journal-title":"Br J Haematol"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<26::AID-AJH6>3.0.CO;2-R","author":"Ohga, S","year":"1999","unstructured":"Ohga S, Kimura N, Takada H, et al. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol. 1999; 61:26-33.","journal-title":"Am J Hematol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00001622-200209000-00010","author":"Lechowicz, MJ","year":"2002","unstructured":"Lechowicz MJ, Lin L, Ambinder RF. Epstein-Barr virus DNA in body fluids. Curr Opin Oncol. 2002;14:533-537.","journal-title":"Curr Opin Oncol"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"Belhadj, K","year":"2003","unstructured":"Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic 33 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261-4269.","journal-title":"Blood"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2559.2000.00804.x","volume":"36","author":"Ohshima, K","year":"2000","unstructured":"Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic 33 T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology. 2000;36:127-135.","journal-title":"Histopathology"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1386-6346(02)00311-X","author":"Shibuya, A","year":"2003","unstructured":"Shibuya A, Tsuchihashi T, Watanabe M, et al. Severe chronic active Epstein-Barr virus infection associated with multiple necrotic lesions in the liver. Hepatol Res. 2003;25:447-454.","journal-title":"Hepatol Res"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1040-8428(02)00116-6","author":"Kawa, K","year":"2002","unstructured":"Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol. 2002;44:251-257.","journal-title":"Crit Rev Oncol Hematol"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1703392","author":"Taketani, T","year":"2002","unstructured":"Taketani T, Kikuchi A, Inatomi J, et al. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002;29:531-533.","journal-title":"Bone Marrow Transplant"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1703796","author":"Okamura, T","year":"2003","unstructured":"Okamura T, Kishimoto T, Inoue M, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disease. Bone Marrow Transplant. 2003;31: 105-111.","journal-title":"Bone Marrow Transplant"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1702999","author":"Minegishi, M","year":"2001","unstructured":"Minegishi M, Ohashi Y, Kumaki S, et al. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2001;27:883-886.","journal-title":"Bone Marrow Transplant"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1704161","author":"Yagi, T","year":"2003","unstructured":"Yagi T, Fujino H, Hirai M, et al. Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer\/T cell lymphoma, nasal type. Bone Marrow Transplant. 2003;32:451-453.","journal-title":"Bone Marrow Transplant"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","author":"Heslop, HE","year":"1996","unstructured":"Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996;2:551-555.","journal-title":"Nat Med"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2249.1996.d01-619.x","volume":"103","author":"Kuzushima, K","year":"1996","unstructured":"Kuzushima K, Yamamoto M, Kimura H, et al. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol. 1996;103:192-198.","journal-title":"Clin Exp Immunol"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.bmt.1701620","author":"Imashuku, S","year":"1999","unstructured":"Imashuku S, Hibi S, Todo S, et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant. 1999;23:569-572.","journal-title":"Bone Marrow Transplant"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.bmt.1702428","author":"Weinthal, JA","year":"2000","unstructured":"Weinthal JA, Goldman SC, Lenarsky C. Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant. 2000;25:1311-1313.","journal-title":"Bone Marrow Transplant"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/JVI.76.10.5071-5081.2002","volume":"76","author":"Wilson, AD","year":"2002","unstructured":"Wilson AD, Morgan AJ. Primary immune responses by cord blood CD4 T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro. J Virol. 2002;76:5071-5081.","journal-title":"J Virol"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2249.1997.258-ce1131.x","volume":"107","author":"Moretta, A","year":"1997","unstructured":"Moretta A, Comoli P, Montagna D, et al. High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production. Clin Exp Immunol. 1997;107:312-320.","journal-title":"Clin Exp Immunol"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/cimm.1999.1514","volume":"195","author":"Sun, Q","year":"1999","unstructured":"Sun Q, Burton RL, Pollok KE, Emanuel DJ, Lucas KG. CD4 Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell Immunol. 1999;195:81-88.","journal-title":"Cell Immunol"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood.V96.8.2814","author":"Marshall, NA","year":"2000","unstructured":"Marshall NA, Howe JG, Formica R, et al. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000;96:2814-2821.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.04081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T02:09:54Z","timestamp":1586052594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.04081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,12,1]]}},"alternative-id":["M7RKW17CB1K9X7Q7"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.04081","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}